Clinical Trial Update: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of abiraterone in men with prostate cancer who have previously received docetaxel has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED